36 articles
Evonik broke ground on an €80 million biotech expansion at its Slovak Fermas site to boost pharmaceutical intermediate production via fermentation, scheduled for completion in early 2028.
Evonik announced plans to close its Hamburg and Bitterfeld production sites by 2027, citing structural inefficiencies and cost competitiveness. This move is part of a broader restructuring strategy to
Evonik announced plans to construct a new GMP-compliant LNP drug production facility in Vancouver with over 150 million CAD investment, targeting 2029 completion. The project will triple existing capa
Evonik concluded its fourth 'Growth Unlimited' vocational empowerment program, releasing a talent capability map to address digital and green transformation needs across seven cities.
Evonik will support Neptune Energy's Altmark lithium extraction project in Germany using its Liocel adsorbent technology during Pilot Phase II. The project targets industrial-scale deployment for a re
Evonik reported a 24% year-on-year increase in adjusted EBITDA to €630 million for Q2 2026, raising its full-year outlook to €2–2.2 billion. Growth stemmed from an 11% sales increase and opportunities
Major European chemical firms including BASF and Evonik reported Q2 earnings beating expectations driven by price increases, prompting raised full-year forecasts despite persistent industry production
Major chemical companies like BASF and Evonik upgraded full-year earnings projections following strong Q2 performance, though raw material cost inflation and geopolitical tensions remain significant h
The German Chemical Industry Association (VCI) downgraded its 2026 production forecast by 1.5%, citing a 3% H1 output decline and high energy costs. Major firms like BASF and Evonik are cutting jobs a
Evonik has launched its AEM anion exchange membrane pilot plant in Marl, Germany, supporting 2.5 GW electrolyzer capacity for cost-effective green hydrogen. The DURAION membranes reduce investment cos
Evonik will invest $100 million over five years to modernize its Lafayette, Indiana facility, enhancing API manufacturing capabilities and automation. This strategic move aims to meet growing US deman
The global specialty chemicals market is projected to reach $834.97 billion by 2026, driven by electronic gases. Major players like Evonik show performance recovery while M&A and capacity expansions a
Evonik raised its 2026 full-year adjusted EBITDA guidance to €2–2.2 billion following a Q2 forecast of €600–650 million, up 23% year-over-year. The upgrade stems from higher volumes and prices, though
Evonik completed the sale of its Hanau, Germany API production assets to ProChem Group to optimize its asset portfolio. The move supports Evonik's strategy to concentrate investments on complex delive
Evonik plans 3,200 job cuts while AbbVie acquires Apogee for nearly $11 billion. C&EN also promotes recent reporting on heavy rare earth extraction in Brazil to counter China's monopoly.
Evonik plans to cut 3,200 jobs globally by 2029 and discontinue its unprofitable polyester business due to weak market dynamics and European structural disadvantages. The move aims to enhance efficien
Evonik and Zeopore launched a new isomerization dewaxing catalyst using mesoporous molecular sieves to boost fuel and lubricant efficiency. The technology reduces product loss and carbon emissions, su
Evonik partnered with MTCO to supply SEPURAN Green membranes for biogas purification in Malaysia. The polyimide technology converts biogas to LNG-quality biomethane with low energy consumption across
Evonik anticipates Q2 market tailwinds driven by customer stockpiling due to Middle East conflict disruptions, with methionine prices rising. Despite a 9% Q1 sales decline, adjusted EBITDA beat foreca
European chemical firms reported strong earnings as Middle East conflicts disrupted Asian feedstock supplies, boosting demand for regional competitors. Major players like Yara and Evonik capitalized o
Evonik Industries inaugurated an expansion of its specialty amine facility in Nanjing, investing double-digit millions to boost supply for polyurethane and epoxy applications. The upgraded plant utili
Evonik unveils advanced polymer solutions at CHINAPLAS 2026 for sectors including new energy vehicles, hydrogen, and personalized medicine. The company also confirmed successful trial production of it
Evonik has appointed Michael Rauch as its new chief financial officer effective May 1. The German chemicals group also extended CEO Christian Kullmann's contract through 2030 following an extraordinar
Evonik unveiled its next-generation DURAION wide-width anion exchange membrane at the 2026 International Hydrogen & Fuel Cell Exhibition, expanding width to 1 meter to facilitate industrial-scale gree
Major chemical firms including Dow, Lanxess, Evonik, and Clariant unveiled new personal care ingredients at PCHi 2026 in Hangzhou. Innovations span silicone gel agents, preservatives, and bio-active c
Evonik is redirecting its research unit's efforts toward established strengths to reduce time to market for specialty chemical products.
Evonik outlined a balanced global growth strategy at the India Chemical Industry Outlook Conference, emphasizing agility and partnerships. The company cited geopolitical uncertainty as a key driver fo
Evonik maintains its earnings outlook and expects no demand recovery until 2026. Q4 operating profits declined yet beat estimates, supported by anticipated savings from its reorganization program.
Evonik plans to expand HTPB production capacity in Germany, with additional capacity scheduled for Q2 2027. The company also announced plans for a new production facility in Asia.
Evonik has expanded its Hiformer PFAS-free liquid additive series to Asia, introducing two new formulations for polyolefin films that improve processing stability and reduce energy consumption.
ChemBrief